Market Currents

• Sunday, September 27, 2009

• 09:48 AM Abbott (ABT) is close to announcing a deal to buy Belgian conglomerate Solvay's (SVYSY.PK) drug unit for about $7.6B in cash. A deal could be announced as early as Monday. Abbott and Solvay already sell two drugs for cholesterol and triglycerides together; a deal would give Abbott access to Solvay's drugs for hypertension and Parkinson's disease. (WSJ) Comment!